Cancer Health Treatment Update Happy holidays from all of us at Cancer Health! Cancer Health Treatment Update Cancer Testing and Diagnosis Dropped During COVID-19 Pandemic New diagnoses of bladder, colorectal, lung and prostate cancer fell during the spring of 2020 and did not return to previous levels. New Hope for Patients With Relapsed Large B-cell Lymphoma Patients treated with Breyanzi CAR-T therapy remained in remission longer than those who received standard care. Leading Efforts Against KRAS, the “Undruggable” Cancer Target Damon Runyon Cancer Research Foundation scientists work to develop drugs for people with KRAS-driven cancers. Breast Cancer Survival Differs Dramatically by Where People Live Women residing in locations with historic housing discrimination have lower breast cancer survival rates. Advertisement FDA Authorizes First Antiviral Pill for COVID-19 Paxlovid, which reduces the risk of hospitalization or death by about 90%, is expected to be a game-changer. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Winter 2022 Check out our latest print edition! Newsfeed Some Doctors Now Recommend Stool-Based Tests Over Colonoscopies New Patient Guidelines for Cervical Cancer The American Cancer Society Releases Updated Report On Cancer Disparities In The U.S. Breast Cancer Survival Differs Dramatically by Where People Live Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer Newsfeed Some Doctors Now Recommend Stool-Based Tests Over Colonoscopies New Patient Guidelines for Cervical Cancer The American Cancer Society Releases Updated Report On Cancer Disparities In The U.S. Breast Cancer Survival Differs Dramatically by Where People Live Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: